FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2164306987> ?p ?o ?g. }

• W2164306987 abstract "Atherosclerotic lesions develop and progress more rapidly in diabetic patients than in nondiabetic individuals. This may be caused by accelerated lesion formation in the high-glucose environment of diabetes. Smooth muscle cells (SMCs) cultured in high glucose are more responsive to growth factors such as insulin-like growth factor-1 (IGF-1). This enhanced response to IGF-1 is due in part to increased activation of the alpha(V)beta(3) integrin. We tested whether alpha(V)beta(3) integrin activation was increased in diabetic animals and whether an antibody to beta(3) would inhibit IGF-1 action and development of atherosclerosis. Eight male pigs were made diabetic with streptozotocin and fed a high-fat diet. A F(ab)(2) antibody fragment directed at beta(3) was infused into one femoral artery, whereas the other artery received control F(ab)(2) for 3.5 months. There was a 65 +/- 8% reduction in atherosclerotic lesion area in the arteries treated with F(ab)(2) antibody to beta(3). Phosphorylation of beta(3) was reduced by 75 +/- 18% in vessels treated with the antibody. Shc and mitogen-activated protein kinase phosphorylation, which are required for IGF-1-stimulated SMC proliferation, were also significantly reduced. We conclude that activation of IGF-1 receptor and alpha(V)beta(3)-linked signaling pathways accelerates atherosclerosis in diabetes and that administration of an antibody to beta(3) to diabetic pigs inhibits alpha(V)beta(3) activation, IGF-1-stimulated signaling, and atherosclerotic lesion development. This approach offers a potential therapeutic approach to the treatment of this disorder." @default.
• W2164306987 created "2016-06-24" @default.
• W2164306987 creator A5000288481 @default.
• W2164306987 creator A5014170799 @default.
• W2164306987 creator A5029593773 @default.
• W2164306987 creator A5032217457 @default.
• W2164306987 creator A5038704186 @default.
• W2164306987 creator A5039368198 @default.
• W2164306987 creator A5059093014 @default.
• W2164306987 creator A5061839093 @default.
• W2164306987 date "2010-02-10" @default.
• W2164306987 modified "2023-09-24" @default.
• W2164306987 title "A Monoclonal Antibody Against α _V β ₃ Integrin Inhibits Development of Atherosclerotic Lesions in Diabetic Pigs" @default.
• W2164306987 cites W1671349458 @default.
• W2164306987 cites W1964975571 @default.
• W2164306987 cites W1965920988 @default.
• W2164306987 cites W1967773283 @default.
• W2164306987 cites W1968142145 @default.
• W2164306987 cites W1969891188 @default.
• W2164306987 cites W1979209283 @default.
• W2164306987 cites W1982158849 @default.
• W2164306987 cites W1991750814 @default.
• W2164306987 cites W1992639178 @default.
• W2164306987 cites W1995770707 @default.
• W2164306987 cites W1997721880 @default.
• W2164306987 cites W2006594678 @default.
• W2164306987 cites W2009540751 @default.
• W2164306987 cites W2016489723 @default.
• W2164306987 cites W2018633162 @default.
• W2164306987 cites W2033648884 @default.
• W2164306987 cites W2036023119 @default.
• W2164306987 cites W2037015118 @default.
• W2164306987 cites W2044212561 @default.
• W2164306987 cites W2044923102 @default.
• W2164306987 cites W2047234062 @default.
• W2164306987 cites W2048326417 @default.
• W2164306987 cites W2048728701 @default.
• W2164306987 cites W2050411677 @default.
• W2164306987 cites W2058099941 @default.
• W2164306987 cites W2059017984 @default.
• W2164306987 cites W2076313199 @default.
• W2164306987 cites W2083079614 @default.
• W2164306987 cites W2083434885 @default.
• W2164306987 cites W2092282197 @default.
• W2164306987 cites W2094469836 @default.
• W2164306987 cites W2096401506 @default.
• W2164306987 cites W2101677747 @default.
• W2164306987 cites W2107719587 @default.
• W2164306987 cites W2108913002 @default.
• W2164306987 cites W2111144663 @default.
• W2164306987 cites W2112692194 @default.
• W2164306987 cites W2115554540 @default.
• W2164306987 cites W2117187625 @default.
• W2164306987 cites W2131289077 @default.
• W2164306987 cites W2134853846 @default.
• W2164306987 cites W2138129993 @default.
• W2164306987 cites W2139933399 @default.
• W2164306987 cites W2148796996 @default.
• W2164306987 cites W2155645904 @default.
• W2164306987 cites W2160235244 @default.
• W2164306987 cites W2162568758 @default.
• W2164306987 cites W2163286721 @default.
• W2164306987 cites W2147568372 @default.
• W2164306987 doi "https://doi.org/10.1126/scitranslmed.3000476" @default.
• W2164306987 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3938114" @default.
• W2164306987 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20371482" @default.
• W2164306987 hasPublicationYear "2010" @default.
• W2164306987 type Work @default.
• W2164306987 sameAs 2164306987 @default.
• W2164306987 citedByCount "35" @default.
• W2164306987 countsByYear W21643069872012 @default.
• W2164306987 countsByYear W21643069872013 @default.
• W2164306987 countsByYear W21643069872014 @default.
• W2164306987 countsByYear W21643069872015 @default.
• W2164306987 countsByYear W21643069872016 @default.
• W2164306987 countsByYear W21643069872017 @default.
• W2164306987 countsByYear W21643069872018 @default.
• W2164306987 countsByYear W21643069872019 @default.
• W2164306987 countsByYear W21643069872021 @default.
• W2164306987 countsByYear W21643069872022 @default.
• W2164306987 countsByYear W21643069872023 @default.
• W2164306987 crossrefType "journal-article" @default.
• W2164306987 hasAuthorship W2164306987A5000288481 @default.
• W2164306987 hasAuthorship W2164306987A5014170799 @default.
• W2164306987 hasAuthorship W2164306987A5029593773 @default.
• W2164306987 hasAuthorship W2164306987A5032217457 @default.
• W2164306987 hasAuthorship W2164306987A5038704186 @default.
• W2164306987 hasAuthorship W2164306987A5039368198 @default.
• W2164306987 hasAuthorship W2164306987A5059093014 @default.
• W2164306987 hasAuthorship W2164306987A5061839093 @default.
• W2164306987 hasBestOaLocation W21643069872 @default.
• W2164306987 hasConcept C11960822 @default.
• W2164306987 hasConcept C126322002 @default.
• W2164306987 hasConcept C134018914 @default.
• W2164306987 hasConcept C141071460 @default.
• W2164306987 hasConcept C142724271 @default.
• W2164306987 hasConcept C159654299 @default.
• W2164306987 hasConcept C170493617 @default.
• W2164306987 hasConcept C195687474 @default.
• W2164306987 hasConcept C199360897 @default.

• next